Delivery Order SPE2DB20D7066-SPE2DB24FC2MF

Award Date 8/2/24
Potential Completion Date 8/23/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The $77,771.83 contract is for the supply of VARIVAX vaccine with diluents, with a period of performance through October 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
The U.S. Defense Logistics Agency (DLA) has awarded a $2,811.03 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of VARIVAX vaccine with diluents. This contract has an ultimate completion date of October 4, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and medical supplies, to support various federal...
The Defense Logistics Agency (DLA) awarded a $1,874.02 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $47,798.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. The contract has an ultimate completion date of May 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,911.94 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of VARIVAX vaccine with diluents and has an ultimate completion date of September 6, 2024. This delivery order falls under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $9,559.70 firm fixed price delivery order for the supply of VARIVAX vaccines and related diluents. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $14,339.55 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment...
The Defense Logistics Agency (DLA) awarded a $7,496.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities and pharmaceutical products to support military treatment programs and facilities...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,867.91 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide VARIVAX vaccine with diluents. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract worth $134,929.44 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VARIVAX vaccine with diluents. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB24FC2MF
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a $19,119.60 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of VARIVAX vaccine with diluents. This order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 23, 2024. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen leverages its extensive supply chain network to provide a wide array of critical care materials, medications, and vaccines to various federal agencies and healthcare providers.

Generated 11/1/24, 9:20 AM